CorMedix (CRMD) Stock: Buy, Sell, or Hold?
$4.92
+0.25 (+5.47%)
▲
5d:
-10.15%
30d:
-32.3%
90d:
-39.84%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Nov 12, 2026
Protect CRMD Gains
Updated Nov 16, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
53/100
Position
OVERSOLD
30-Day Fair Range
$5.42 – $7.83
Position: OVERSOLD
Forward P/E & Valuation
49.1x
CHEAP
vs 59.9x historical avg
Wall Street Target
$15.60
+234.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.65 / $5.79
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: CRMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When CRMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CRMD is currently trading at $4.92, which is considered oversold relative to its 30-day fair value range of $5.42 to $7.83. From a valuation perspective, the stock is trading at a discount (Forward PE: 49.0) compared to its historical average (59.9). Remarkably, the market is currently pricing in an annual earnings decline of 6.5% over the next few years. This pessimistic expectation contrasts with the company's recent 6.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CRMD is in a downtrend. Immediate support is located at $4.65, while resistance sits at $5.79. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: CRMD scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.60 (+234.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CRMD is in a downtrend. Immediate support is located at $4.65, while resistance sits at $5.79. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: CRMD scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.60 (+234.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.42 -
$7.83
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
Trading Range & Key Levels
30-Day Trading Range
$5.42 -
$7.83
Current vs Trading Range
OVERSOLD
Support Level
$4.65
Resistance Level
$5.79
Current Trend
Downtrend
Technical data as of
Nov 16, 2026
Protect Your Profits
Holding CRMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanInstitutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Active Quantitative Risk Vetoes (1)
Attention Chase Risk: msg spike z=2.0 (24 vs ~9/day), 5d move -6.4%
Phase & Gamma Walls
BREAKDOWN
Days in Phase:
109d (53% conf)
Technical Setup Structure
MONITORING
Absorption:
Inactive (CMF -0.24)
Pullback / Drawdown:
-58.4% from 52W High
Consolidation:
Trending (ADX 32.9)
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.5%)
- BULLISH: Trading 234.8% below Wall St target ($15.60)
- CAUTION: Bottoming setup, but lagging the sector by 19% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-10.1%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
49.05
Wall Street Target
$15.60
(+234.8%)
Revenue Growth (YoY)
-47.7%
Earnings Growth (YoY)
6.7%
Profit Margin
15.5%
Valuation Discount vs History
-6.5% cheaper
PE vs Historical
49.1 vs 59.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.5%
(market-implied from PE analysis)
1-Year Target
$4.36
(-7%)
2-Year Target
$4.07
(-13%)
3-Year Target
$3.81
(-18%)
3-Yr Target (if PE normalizes)
(PE: 49→60)
$4.65
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 49.1, Growth: -82.5%)
$3.40
(+-27%)
Base:
(SPY PE: 19.9, Growth: -82.5%)
$1.38
(-71%)
Bear:
(PE: 16.9, Growth: -82.5%)
$1.17
(-75%)
📈
Valuation based on Current Earnings
Trailing PE: 2.36 | Current EPS (TTM): $2.05
Bull Case
$2.66
(-43%)
Analyst growth -50.0%, PE expands to 2.6
Base Case
$2.42
(-48%)
Market implied -50.0%, PE stable at 2.4
Bear Case
$3.29
(-29%)
Severe decline -20.0%, PE contracts to 2.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 49.1 to 59.9
Stabilization Target:
$5.69
(+22.1%)
PE Expansion Potential:
+22.1%
Share CRMD Analysis
Share this live CRMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CRMD)
Bullish
12 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
11 msgs
24h retail stream
Last Tracked
Nov 16, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages show overwhelmingly bullish sentiment towards $CRMD, with several traders expressing confidence in the stock after the CEO's recent large purchase of shares.
Key Retail Themes:
CEO buying
Insider buying
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 16, 2026 1:55 PM ET
Data refreshes hourly during market hours. Next update: 2:55 PM
Data refreshes hourly during market hours. Next update: 2:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$300 | 60 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$595 | 35 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$315 | 34 SELL |
|
IDYA
Ideaya Biosciences Inc |
STRONG BUY
16 analysts |
$51 | 60 BUY |
|
PVLA
Palvella Therapeutics, I… |
STRONG BUY
16 analysts |
$234 | 49 HOLD |
Advanced CRMD Option Strategies
Professional options setups generated by AI based on today's CRMD price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CRMD Research Pages
CRMD Technical Chart
CRMD Price Prediction
CRMD Intrinsic Value DCF
CRMD Earnings Date
Why is CRMD Moving Today?
CRMD Investment Advisor
CRMD Fair Price Analyzer
CRMD Target Price Playground
CRMD LEAP Simulator
CRMD Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
CRMD Options Chain
CRMD Options Advisor
CRMD Options Analysis
CRMD Competitors
Part B: Tradestie Flagship Market Scanners